REFERENCES
- Broecker BH, Klein FA, Hackler RH. Cancer of the bladder in spinal cord injury patients. J Urol 1981; 125: 196–7.
- Melzak J. The incidence of bladder cancer in paraplegia. Paraplegia 1966; 4: 85–96.
- Locke JR, Hill DE, Walzer Y. Incidence of squamous cell carcinoma in patients with long-term catheter drainage. J Urol 1985; 133: 1034–5.
- Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF Jr. Urinary tract infection and risk of bladder cancer. Am J Epidem 1984; 119: 510–5.
- Utz DC, Hanash KA, Farrow GM. The plight of the patient with carcinoma in situ of the bladder. J Urol 1970; 103: 160–4.
- Farrow GM, Utz DC. Observations on microinvasive transitional cell carcinoma of the urinary bladder. Clin Oncol 1982; 1: 609.
- Prout GR Jr, Griffin PP, Daly JJ. The outcome of conservative treatment of carcinoma in situ of the bladder. J Urol 1987; 138: 766–70.
- Profio AE, Balchum OJ. Fluorescence diagnosis of cancer. In: Kessel D (ed). Porphyrin photosensitization workshop. New York; Plenum Press, 1985.
- Kelly JF, Snell ME. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 1976; 115: 150–1.
- Baert L, Berg R, Van Damme B, et al. Clinical fluorescence diagnosis of human bladder carcinoma following low-dose Photofrin injection. Urol 1993; 41: 322–30.
- D'Hallewin MA, Baert L, Vanherzeele H. Cytoscopic photodetection of human bladder carcinoma without sensitizing agents. In: LEOS ‘93 Conference Proceedings. Piscataway, NY; IEEE. Lasers and Electro Optics Society, 1993: 245.
- D'Hallewin MA, Baert L, Vanherzeele H. Autofluorescence demarcation of human bladder carcinoma with a frequency tripled Nd YAG laser. Br J Urol, submitted.
- Schwartz JP, Passonneau JV, Johnson GS, Pastan I. The effect of growth conditions on NAD+ and NADH concentrations and the NAD+: NADH ratio in normal and transformed fibroblasts. J Biol Chem 1974; 249: 4138–43.